Amylin Receptor Agonist and GLP-1 Receptor Agonist Combination Therapy
Summary
USPTO published patent application US20260091086A1 for a combination therapy comprising amylin receptor agonists and GLP-1 receptor agonists. The application, filed on May 19, 2025, covers polypeptide combinations for therapeutic uses including weight management (A61P 3/04). Invented by Sarah WILL, the application represents a potential new approach to metabolic disorder treatment.
What changed
USPTO published patent application US20260091086A1 on April 2, 2026, covering a combination of amylin receptor agonists and GLP-1 receptor agonists. The application includes claims for therapeutic polypeptide combinations classified under A61K 38/26, A61K 38/22, and A61P 3/04, with CPC classifications C07K 14/575 and C07K 14/605. Application No. 19212361 was filed on May 19, 2025, by inventor Sarah WILL.
Pharmaceutical companies developing weight management or metabolic disorder treatments should review the application claims to assess potential freedom-to-operate implications or opportunities for licensing. Patent applications are published 18 months after filing; this publication represents an early-stage intellectual property claim rather than regulatory approval or market authorization.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
POLYPEPTIDE COMBINATIONS AND USES THEREOF
Application US20260091086A1 Kind: A1 Apr 02, 2026
Inventors
Sarah WILL
Abstract
The present invention relates to a combination of polypeptides and uses thereof. In particular, the present invention relates to a combination of an amylin receptor agonist and a GLP-1 receptor agonist, and uses thereof.
CPC Classifications
A61K 38/26 A61K 38/22 A61P 3/04 C07K 14/575 C07K 14/605 C07K 2319/00
Filing Date
2025-05-19
Application No.
19212361
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.